ClinicalThought

Share

Program Content

Activities

  • Renal Protection in T2D
    Why I Recommend SGLT2 Inhibitors for Renal Protection in Patients With T2D
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 21, 2021

    Expires: June 20, 2022

Faculty

cover img faculity

Richard E. Pratley, MD

Samuel E. Crockett Chair in Diabetes Research
Medical Director
AdventHealth Diabetes Institute
Senior Investigator and Diabetes Program Lead
AdventHealth Translational Research Institute
Adjunct Professor of Medicine
Johns Hopkins University School of Medicine 
Orlando, Florida

Provided by

ProCE Banner

Supporters

Merck